JOSEPH N TROPEA
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology PHILADELPHIA, PA NPI 1013028729
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology PA Daiichi Sankyo Inc. All categories
General Payments — all program years on this page
$16,586.33
- Category: General Payments
- Program years: PY2018–2024
- Record count: 633
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,093.04 across 53 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $994.04 | 52 |
| Education | $99.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $173.21 | 8 |
| PFIZER INC. | $141.75 | 8 |
| ABBVIE INC. | $140.92 | 2 |
| E.R. Squibb & Sons, L.L.C. | $137.23 | 9 |
| SOBI, INC | $116.37 | 2 |
| Acerta Pharma LLC | $51.67 | 3 |
| Celgene Corporation | $51.64 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $49.57 | 3 |
| ARRAY BIOPHARMA INC | $44.68 | 4 |
| Merck Sharp & Dohme Corporation | $34.86 | 2 |
| Gilead Sciences, Inc. | $33.65 | 2 |
| Lilly USA, LLC | $29.71 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.69 | 1 |
| ADC Therapeutics America, Inc. | $19.52 | 1 |
| EISAI INC. | $18.49 | 1 |
| TAIHO ONCOLOGY, INC. | $14.06 | 1 |
| Astellas Pharma US Inc | $14.02 | 1 |
By program year
Records — PY2024 (53)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.